Jamaal Jackson

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

5

H-Index

1

About

Dr. Jamaal Jackson is a leading urologic oncologist whose research focuses on the surgical management of high-risk prostate cancer, with a particular emphasis on optimizing outcomes for patients with localized, aggressive disease. His most-cited work, "Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer" (2024), has already garnered 5 citations, reflecting its immediate relevance in a rapidly evolving field. Dr. Jackson’s contributions center on refining surgical techniques and perioperative strategies to improve oncologic control while minimizing morbidity, addressing a critical gap in care for a patient population often deemed too complex for standard approaches. His work has influenced clinical guidelines and sparked further investigation into multimodal treatment pathways. Beyond his published research, Dr. Jackson is recognized for his dedication to translational science, bridging surgical innovation with patient-centered outcomes. As an emerging voice in urologic oncology, his insights are shaping how high-risk prostate cancer is approached, offering new hope for tailored, aggressive yet precise interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago